Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging

Bruce Luber, Shawn M. McClintock, Sarah H. Lisanby

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Transcranial magnetic stimulation (TMS) can be used to probe cortical function and treat neuropsychiatric illnesses. TMS has demonstrated neuroplastic effects akin to longterm potentiation and long-term depression, and therapeutic applications are in development for post-stroke recovery, Alzheimer's disease, and depression in seniors. Here, we discuss two new directions of TMS research relevant to cerebral aging and cognition. First, we introduce a paradigm forenhancing cognitive reserve, based on our research in sleep deprivation. Second, we discuss the use of magnetic seizure therapy (MST) to spare cognitive functions relative to conventional electroconvulsive therapy, and as a means of providing a more potent antidepressant treatment when subconvulsive TMS has shown modest efficacy in seniors. Whether in the enhancement of cognition as a treatment goal, or in the reduction of amnesia as a side effect, these approaches to the use of TMS and MST merit further exploration regarding their clinical potential.

Original languageEnglish (US)
Pages (from-to)87-98
Number of pages12
JournalDialogues in Clinical Neuroscience
Volume15
Issue number1
StatePublished - Mar 1 2013

Fingerprint

Transcranial Magnetic Stimulation
Seizures
Cognition
Cognitive Reserve
Depression
Therapeutics
Electroconvulsive Therapy
Sleep Deprivation
Amnesia
Long-Term Potentiation
Research
Antidepressive Agents
Alzheimer Disease
Stroke

Keywords

  • Aging
  • Magnetic Seizure Therapy
  • MST
  • Neuroplasticity
  • Neuroscience
  • TMS
  • Transcranial Magnetic Stimulation

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

@article{10035e966f0b4bc1b9e96a3605590459,
title = "Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging",
abstract = "Transcranial magnetic stimulation (TMS) can be used to probe cortical function and treat neuropsychiatric illnesses. TMS has demonstrated neuroplastic effects akin to longterm potentiation and long-term depression, and therapeutic applications are in development for post-stroke recovery, Alzheimer's disease, and depression in seniors. Here, we discuss two new directions of TMS research relevant to cerebral aging and cognition. First, we introduce a paradigm forenhancing cognitive reserve, based on our research in sleep deprivation. Second, we discuss the use of magnetic seizure therapy (MST) to spare cognitive functions relative to conventional electroconvulsive therapy, and as a means of providing a more potent antidepressant treatment when subconvulsive TMS has shown modest efficacy in seniors. Whether in the enhancement of cognition as a treatment goal, or in the reduction of amnesia as a side effect, these approaches to the use of TMS and MST merit further exploration regarding their clinical potential.",
keywords = "Aging, Magnetic Seizure Therapy, MST, Neuroplasticity, Neuroscience, TMS, Transcranial Magnetic Stimulation",
author = "Bruce Luber and McClintock, {Shawn M.} and Lisanby, {Sarah H.}",
year = "2013",
month = "3",
day = "1",
language = "English (US)",
volume = "15",
pages = "87--98",
journal = "Dialogues in Clinical Neuroscience",
issn = "1294-8322",
publisher = "Servier International",
number = "1",

}

TY - JOUR

T1 - Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging

AU - Luber, Bruce

AU - McClintock, Shawn M.

AU - Lisanby, Sarah H.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Transcranial magnetic stimulation (TMS) can be used to probe cortical function and treat neuropsychiatric illnesses. TMS has demonstrated neuroplastic effects akin to longterm potentiation and long-term depression, and therapeutic applications are in development for post-stroke recovery, Alzheimer's disease, and depression in seniors. Here, we discuss two new directions of TMS research relevant to cerebral aging and cognition. First, we introduce a paradigm forenhancing cognitive reserve, based on our research in sleep deprivation. Second, we discuss the use of magnetic seizure therapy (MST) to spare cognitive functions relative to conventional electroconvulsive therapy, and as a means of providing a more potent antidepressant treatment when subconvulsive TMS has shown modest efficacy in seniors. Whether in the enhancement of cognition as a treatment goal, or in the reduction of amnesia as a side effect, these approaches to the use of TMS and MST merit further exploration regarding their clinical potential.

AB - Transcranial magnetic stimulation (TMS) can be used to probe cortical function and treat neuropsychiatric illnesses. TMS has demonstrated neuroplastic effects akin to longterm potentiation and long-term depression, and therapeutic applications are in development for post-stroke recovery, Alzheimer's disease, and depression in seniors. Here, we discuss two new directions of TMS research relevant to cerebral aging and cognition. First, we introduce a paradigm forenhancing cognitive reserve, based on our research in sleep deprivation. Second, we discuss the use of magnetic seizure therapy (MST) to spare cognitive functions relative to conventional electroconvulsive therapy, and as a means of providing a more potent antidepressant treatment when subconvulsive TMS has shown modest efficacy in seniors. Whether in the enhancement of cognition as a treatment goal, or in the reduction of amnesia as a side effect, these approaches to the use of TMS and MST merit further exploration regarding their clinical potential.

KW - Aging

KW - Magnetic Seizure Therapy

KW - MST

KW - Neuroplasticity

KW - Neuroscience

KW - TMS

KW - Transcranial Magnetic Stimulation

UR - http://www.scopus.com/inward/record.url?scp=84876802367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876802367&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 87

EP - 98

JO - Dialogues in Clinical Neuroscience

JF - Dialogues in Clinical Neuroscience

SN - 1294-8322

IS - 1

ER -